11 Iino Y, Toriyama M, Ogawa H, et al. Cholesteatoma debris as an activator of human monocytes. Acta Otolaryngol (Stockh), 1990,110: 410～415.
22 Kinoshita K. The role of interleukin-1 alpha, tumor necrosis factor-alpha and parathyroid hormone-related protein in bone resorption of cholesteatoma otitis. Nippon-Jibiinkoka-Gakkai-Kaiho, 1994 Aug, 97(8): 1472～1480.
33 Yan S, Huang CC. The role of tumor necrosis factor-a in bone resorption of cholesteatoma. American Journal of Otolaryngology, 1991, 100:85～88.
44 Chodynicki S, Soroczynska J.TNT alpha in serum of patients with cholesteatoma. Otolaryngol Pol, 1994, 48(3):279～281.
55 Amar MS, Wishahi HF, Zakhary MM. Clinical and biochemical studies of bone destruction in cholesteatoma. The Journal of Laryngology and Otology, 1996, 110:543～539.
66 Yan S, Huang CC. Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro. Annals of Otology, Rhinology and Laryngology, 1991,100:157～161.
4Wang SY,Gao J,Lei QY, et al.Prostate-specific deletion of the mnrine PTENtumor suppressor gene leads to metastatic prostate cancer[J].Cancer ce11,2003,4(3) :209-210.
5Chu EC,Tarnawski AS.PTEN regulatory functions in tumor suppression and cell biology[J].Med Sci Monit,2004,10(10): 235-241.
6M. Schmidt,P. Grünsfelder,F. Hoppe. Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts[J] 2000,European Archives of Oto - Rhino - Laryngology(8):425～429
